Jed Latkin | CEO |
Erika Gibson | Director, Finance & Administration |
Dr. Mike Rosol | Chief Medical & Science Officer |
Bill Regan | Chief Compliance & Regulatory Officer |
Jason McCarthy | Maxim Group |
Greetings and welcome to Navidea Biopharmaceuticals' Q1 2019 Earnings Conference Call. At this time, all participants are in listen-only-mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr.